Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The daily Top 10 COVID papers


  Depression

  Free Subscription


Articles published in Pharmacol Biochem Behav

Retrieve available abstracts of 42 articles:
HTML format



Single Articles


    February 2021
  1. WANG XL, Wang DQ, Jiao FC, Ding KM, et al
    Retraction notice to "Diurnal rhythm disruptions induced by chronic unpredictable stress relate to depression-like behaviors in rats" [Pharmacol. Biochem. Behav. 194 (2020) 172939].
    Pharmacol Biochem Behav. 2021;203:173130.
    PubMed     Abstract available


    November 2020
  2. LIU R, Wu XM, He X, Wang RZ, et al
    Contribution of DNA methyltransferases to spared nerve injury induced depression partially through epigenetically repressing Bdnf in hippocampus: Reversal by ketamine.
    Pharmacol Biochem Behav. 2020 Nov 24:173079. doi: 10.1016/j.pbb.2020.173079.
    PubMed     Abstract available


    October 2020
  3. CHRISSOBOLIS S, Luu A, Waldschmidt R, Yoakum M, et al
    Targeting the renin angiotensin system for the treatment of anxiety and depression.
    Pharmacol Biochem Behav. 2020 Oct 25:173063. doi: 10.1016/j.pbb.2020.173063.
    PubMed     Abstract available


  4. SAAVEDRA JS, Garrett PI, Honeycutt SC, Peterson AM, et al
    Assessment of the rapid and sustained antidepressant-like effects of dextromethorphan in mice.
    Pharmacol Biochem Behav. 2020;197:173003.
    PubMed     Abstract available


  5. SMAIL MA, Smith BL, Nawreen N, Herman JP, et al
    Differential impact of stress and environmental enrichment on corticolimbic circuits.
    Pharmacol Biochem Behav. 2020;197:172993.
    PubMed     Abstract available


    July 2020
  6. SPARLING JE, Barbeau K, Boileau K, Konkle ATM, et al
    Environmental enrichment and its influence on rodent offspring and maternal behaviours, a scoping style review of indices of depression and anxiety.
    Pharmacol Biochem Behav. 2020 Jul 20:172997. doi: 10.1016/j.pbb.2020.172997.
    PubMed     Abstract available


    June 2020
  7. KOTANSKA M, Mika K, Salaciak K, Wheeler L, et al
    Pitolisant protects mice chronically treated with corticosterone from some behavioral but not metabolic changes in corticosterone-induced depression model.
    Pharmacol Biochem Behav. 2020;196:172974.
    PubMed     Abstract available


    May 2020
  8. WANG XL, Wang DQ, Jiao FC, Ding KM, et al
    Diurnal rhythm disruptions induced by chronic unpredictable stress relate to depression-like behaviors in rats.
    Pharmacol Biochem Behav. 2020;194:172939.
    PubMed     Abstract available


  9. PHAM TH, Defaix C, Nguyen TML, Mendez-David I, et al
    Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine.
    Pharmacol Biochem Behav. 2020;192:172913.
    PubMed     Abstract available


  10. AN Q, Li C, Chen Y, Yang Y, et al
    Scaffold hopping of agomelatine leads to enhanced antidepressant effects by modulation of gut microbiota and host immune responses.
    Pharmacol Biochem Behav. 2020;192:172910.
    PubMed     Abstract available


    March 2020
  11. WEI Y, Chang L, Hashimoto K
    A historical review of antidepressant effects of ketamine and its enantiomers.
    Pharmacol Biochem Behav. 2020;190:172870.
    PubMed     Abstract available


  12. WITKIN JM
    mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine-associated side-effects.
    Pharmacol Biochem Behav. 2020;190:172854.
    PubMed     Abstract available


  13. LAINIOLA M, Linden AM, Aitta-Aho T
    Behavioral responses of mGluR3-KO mice to the lipopolysaccharide-induced innate inflammatory reaction.
    Pharmacol Biochem Behav. 2020;190:172852.
    PubMed     Abstract available


    February 2020
  14. YOKOYAMA R, Higuchi M, Tanabe W, Tsukada S, et al
    (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
    Pharmacol Biochem Behav. 2020 Feb 20:172876. doi: 10.1016/j.pbb.2020.172876.
    PubMed     Abstract available


    January 2020
  15. GILBERT JR, Zarate CA Jr
    Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation.
    Pharmacol Biochem Behav. 2020 Jan 17:172856. doi: 10.1016/j.pbb.2020.172856.
    PubMed     Abstract available


  16. DEYAMA S, Duman RS
    Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
    Pharmacol Biochem Behav. 2020;188:172837.
    PubMed     Abstract available


  17. POLESZAK E, Wosko S, Slawinska K, Wyska E, et al
    Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice.
    Pharmacol Biochem Behav. 2020;188:172833.
    PubMed     Abstract available


  18. KATO T, Duman RS
    Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms.
    Pharmacol Biochem Behav. 2020;188:172827.
    PubMed     Abstract available


    December 2019
  19. WROBEL A, Serefko A, Wozniak A, Kociszewski J, et al
    Duloxetine reverses the symptoms of overactive bladder co-existing with depression via the central pathways.
    Pharmacol Biochem Behav. 2019 Dec 31:172842. doi: 10.1016/j.pbb.2019.172842.
    PubMed     Abstract available


  20. BAVARESCO DV, Uggioni MLR, Ferraz SD, Marques RMM, et al
    Efficacy of infliximab in treatment-resistant depression: A systematic review and meta-analysis.
    Pharmacol Biochem Behav. 2019;188:172838.
    PubMed     Abstract available


    September 2019
  21. LI Q, Wu HR, Fan SJ, Liu DX, et al
    The effects of sub-anesthetic ketamine plus ethanol on behaviors and apoptosis in the prefrontal cortex and hippocampus of adolescent rats.
    Pharmacol Biochem Behav. 2019;184:172742.
    PubMed     Abstract available


  22. XUE SS, Xue F, Ma QR, Wang SQ, et al
    Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling.
    Pharmacol Biochem Behav. 2019;184:172738.
    PubMed     Abstract available


    August 2019
  23. BAMPI SR, Casaril AM, Sabedra Sousa FS, Pesarico AP, et al
    Repeated administration of a selenium-containing indolyl compound attenuates behavioural alterations by streptozotocin through modulation of oxidative stress in mice.
    Pharmacol Biochem Behav. 2019;183:46-55.
    PubMed     Abstract available


  24. SUZUKI A, Murakami K, Tajima Y, Hara H, et al
    TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats.
    Pharmacol Biochem Behav. 2019;183:80-86.
    PubMed     Abstract available


  25. MAKINO M, Takahashi-Ito K, Murasawa H, Pawlak A, et al
    Memantine ameliorates learning and memory disturbance and the behavioral and psychological symptoms of dementia in thiamine-deficient mice.
    Pharmacol Biochem Behav. 2019;183:6-13.
    PubMed     Abstract available


    June 2019
  26. CHANG L, Zhang K, Pu Y, Qu Y, et al
    Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.
    Pharmacol Biochem Behav. 2019;181:53-59.
    PubMed     Abstract available


    May 2019
  27. NASERZADEH R, Abad N, Ghorbanzadeh B, Dolatshahi M, et al
    Simvastatin exerts antidepressant-like activity in mouse forced swimming test: Role of NO-cGMP-KATP channels pathway and PPAR-gamma receptors.
    Pharmacol Biochem Behav. 2019;180:92-100.
    PubMed     Abstract available


    March 2019
  28. CHAVES RC, Mallmann ASV, Oliveira NF, Oliveira ICM, et al
    Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice.
    Pharmacol Biochem Behav. 2019;180:44-51.
    PubMed     Abstract available


    February 2019
  29. ERICKSON EK, Grantham EK, Warden AS, Harris RA, et al
    Neuroimmune signaling in alcohol use disorder.
    Pharmacol Biochem Behav. 2019;177:34-60.
    PubMed     Abstract available


    January 2019
  30. XIONG Z, Zhang K, Ishima T, Ren Q, et al
    Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
    Pharmacol Biochem Behav. 2019;176:57-62.
    PubMed     Abstract available


    December 2018
  31. HUANG N, Hua D, Zhan G, Li S, et al
    Role of Actinobacteria and Coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression.
    Pharmacol Biochem Behav. 2018;176:93-100.
    PubMed     Abstract available


    July 2018
  32. METHUKU KR, Li X, Cerne R, Gleason SD, et al
    An antidepressant-related pharmacological signature for positive allosteric modulators of alpha2/3-containing GABAA receptors.
    Pharmacol Biochem Behav. 2018;170:9-13.
    PubMed     Abstract available


    June 2018
  33. WANG Q, Dong X, Li N, Wang Y, et al
    JSH-23 prevents depressive-like behaviors in mice subjected to chronic mild stress: Effects on inflammation and antioxidant defense in the hippocampus.
    Pharmacol Biochem Behav. 2018;169:59-66.
    PubMed     Abstract available


    May 2018
  34. TCHEKALAROVA J, Stoynova T, Ilieva K, Mitreva R, et al
    Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light.
    Pharmacol Biochem Behav. 2018 May 25. pii: S0091-3057(18)30151.
    PubMed     Abstract available


    March 2018
  35. OLNEY JJ, Marshall SA, Thiele TE
    Assessment of depression-like behavior and anhedonia after repeated cycles of binge-like ethanol drinking in male C57BL/6J mice.
    Pharmacol Biochem Behav. 2018;168:1-7.
    PubMed     Abstract available


    August 2017
  36. OMAR NN, Tash RF
    Fluoxetine coupled with zinc in a chronic mild stress model of depression: Providing a reservoir for optimum zinc signaling and neuronal remodeling.
    Pharmacol Biochem Behav. 2017;160:30-38.
    PubMed     Abstract available


    June 2017
  37. DU Y, Liang H, Zhang L, Fu F, et al
    Administration of Huperzine A exerts antidepressant-like activity in a rat model of post-stroke depression.
    Pharmacol Biochem Behav. 2017;158:32-38.
    PubMed     Abstract available


  38. ZHOU D, Zhang Z, Liu L, Li C, et al
    The antidepressant-like effects of biperiden may involve BDNF/TrkB signaling-mediated BICC1 expression in the hippocampus and prefrontal cortex of mice.
    Pharmacol Biochem Behav. 2017;157:47-57.
    PubMed     Abstract available


    March 2017
  39. KANDASAMY R, Lee AT, Morgan MM
    Depression of home cage wheel running is an objective measure of spontaneous morphine withdrawal in rats with and without persistent pain.
    Pharmacol Biochem Behav. 2017 Mar 30. pii: S0091-3057(17)30051.
    PubMed     Abstract available


    February 2017
  40. YANG R, Wang P, Chen Z, Hu W, et al
    WY-14643, a selective agonist of peroxisome proliferator-activated receptor-alpha, ameliorates lipopolysaccharide-induced depressive-like behaviors by preventing neuroinflammation and oxido-nitrosative stress in mice.
    Pharmacol Biochem Behav. 2017;153:97-104.
    PubMed     Abstract available


    April 2016
  41. TURGEON SM, Townsend SE, Dixon RS, Hickman ET, et al
    Chronic caffeine produces sexually dimorphic effects on amphetamine-induced behavior, anxiety and depressive-like behavior in adolescent rats.
    Pharmacol Biochem Behav. 2016;143:26-33.
    PubMed     Abstract available


    January 2016
  42. ZHANG H, Li Z, Zhou Z, Yang H, et al
    Antidepressant-like effects of ginsenosides: A comparison of ginsenoside Rb3 and its four deglycosylated derivatives, Rg3, Rh2, compound K, and 20(S)-protopanaxadiol in mice models of despair.
    Pharmacol Biochem Behav. 2016;140:17-26.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Depression is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: